Previous studies have demonstrated that the activation of the NF-κB signaling pathway can exacerbate renal fibrosis, whereas the inhibition of NF-κB signaling pathway activation can ameliorate renal injury (Moller-Hackbarth et al., 2021). This evidence concerns the gene NFKB1 and renal fibrosis.